133 related articles for article (PubMed ID: 32453481)
1. Development of second primary tumors and outcomes in medulloblastoma by treatment modality: A Surveillance, Epidemiology, and End Results analysis.
Nantavithya C; Paulino AC; Liao K; McGovern SL; Grosshans DR; McAleer MF; Woodhouse KD; Khatua S; Chintagumpala MM; Majd NK; Yeboa DN
Pediatr Blood Cancer; 2020 Aug; 67(8):e28373. PubMed ID: 32453481
[TBL] [Abstract][Full Text] [Related]
2. Prolongation of radiotherapy duration is associated with inferior overall survival in patients with pediatric medulloblastoma and central nervous system primitive neuroectodermal tumors.
Baliga S; Bajaj BVM; Kabarriti R; Grassberger C; Patteson B; Yeap B; Fox JL; Garg MK; Yock TI
Pediatr Blood Cancer; 2020 Oct; 67(10):e28558. PubMed ID: 32710698
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors and secondary malignancies in childhood medulloblastoma.
Stavrou T; Bromley CM; Nicholson HS; Byrne J; Packer RJ; Goldstein AM; Reaman GH
J Pediatr Hematol Oncol; 2001 Oct; 23(7):431-6. PubMed ID: 11878577
[TBL] [Abstract][Full Text] [Related]
4. The UK Experience of a Treatment Strategy for Pediatric Metastatic Medulloblastoma Comprising Intensive Induction Chemotherapy, Hyperfractionated Accelerated Radiotherapy and Response Directed High Dose Myeloablative Chemotherapy or Maintenance Chemotherapy (Milan Strategy).
Vivekanandan S; Breene R; Ramanujachar R; Traunecker H; Pizer B; Gaze MN; Saran F; Thorp N; English M; Wheeler KA; Michalski A; Walker DA; Saunders D; Cowie F; Cameron A; Picton SV; Parashar D; Horan G; Williams MV
Pediatr Blood Cancer; 2015 Dec; 62(12):2132-9. PubMed ID: 26274622
[TBL] [Abstract][Full Text] [Related]
5. Treatment of pediatric average-risk medulloblastoma using craniospinal irradiation less than 2500 cGy and chemotherapy: single center experience in Korea.
Yoon JH; Park KD; Kang HJ; Kim H; Lee JW; Kim SK; Wang KC; Park SH; Kim IH; Shin HY
World J Pediatr; 2017 Aug; 13(4):367-373. PubMed ID: 28550392
[TBL] [Abstract][Full Text] [Related]
6. Survival impact of postoperative radiotherapy timing in pediatric and adolescent medulloblastoma.
Chin AL; Moding EJ; Donaldson SS; Gibbs IC; Soltys SG; Hiniker SM; Pollom EL
Neuro Oncol; 2018 Jul; 20(8):1133-1141. PubMed ID: 29309676
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors after extraneural metastasis of medulloblastoma.
Mazloom A; Zangeneh AH; Paulino AC
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):72-8. PubMed ID: 20133080
[TBL] [Abstract][Full Text] [Related]
8. Childhood medulloblastoma-a single institution's historical perspective on survival and functional morbidity.
Phipps K; Kirkman MA; Aquilina K; Gaze M; Michalski A; Wade A; Hayward R
Childs Nerv Syst; 2019 Dec; 35(12):2327-2338. PubMed ID: 31686139
[TBL] [Abstract][Full Text] [Related]
9. Medulloblastoma--a retrospective analysis.
Awasthy BS; Das Gupta C; Singh R; Patel AK; Julka PK
Indian J Pediatr; 1997; 64(5):693-7. PubMed ID: 10771904
[TBL] [Abstract][Full Text] [Related]
10. Late Morbidity and Mortality Among Medulloblastoma Survivors Diagnosed Across Three Decades: A Report From the Childhood Cancer Survivor Study.
Salloum R; Chen Y; Yasui Y; Packer R; Leisenring W; Wells E; King A; Howell R; Gibson TM; Krull KR; Robison LL; Oeffinger KC; Fouladi M; Armstrong GT
J Clin Oncol; 2019 Mar; 37(9):731-740. PubMed ID: 30730781
[TBL] [Abstract][Full Text] [Related]
11. The therapeutic outcome of medulloblastoma in 49 children.
Jaing TH; Hung IJ; Yang CP; Wang HS; Hung PC
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1995; 36(4):279-85. PubMed ID: 7572172
[TBL] [Abstract][Full Text] [Related]
12. Children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor in Norway from 1974 through 2013: Unexplainable regional differences in survival.
Stensvold E; Myklebust TÅ; Cappelen J; Due-Tønnessen BJ; Due-Tønnessen P; Kepka A; Johannesen TB; Krossnes B; Lundar T; Maric S; Miletic H; Moholdt V; Myrmel KS; Nordberg T; Rydland J; Stokland T; Solem K; Solheim O; Torsvik I; Wikran GC; Zeller B; Wesenberg F; Bechensteen AG; Brandal P
Pediatr Blood Cancer; 2019 Oct; 66(10):e27910. PubMed ID: 31264356
[TBL] [Abstract][Full Text] [Related]
13. Medulloblastoma: conventional radiation therapy in comparison to chemo radiation therapy in the post-operative treatment of high-risk patients.
Abd El-Aal HH; Mokhtar MM; Habib E; El-Kashef AT; Fahmy ES
J Egypt Natl Canc Inst; 2005 Dec; 17(4):301-7. PubMed ID: 17102823
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant chemotherapy and overall survival in adult medulloblastoma.
Kann BH; Lester-Coll NH; Park HS; Yeboa DN; Kelly JR; Baehring JM; Becker KP; Yu JB; Bindra RS; Roberts KB
Neuro Oncol; 2017 Feb; 19(2):259-269. PubMed ID: 27540083
[TBL] [Abstract][Full Text] [Related]
15. Clinical Outcomes Among Children With Standard-Risk Medulloblastoma Treated With Proton and Photon Radiation Therapy: A Comparison of Disease Control and Overall Survival.
Eaton BR; Esiashvili N; Kim S; Weyman EA; Thornton LT; Mazewski C; MacDonald T; Ebb D; MacDonald SM; Tarbell NJ; Yock TI
Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):133-138. PubMed ID: 26700707
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of salvage re-irradiation in recurrent medulloblastoma correlate with age at initial diagnosis, primary risk-stratification, and molecular subgrouping.
Gupta T; Maitre M; Sastri GJ; Krishnatry R; Shirsat N; Epari S; Sahay A; Chinnaswamy G; Patil V; Shetty P; Moiyadi A
J Neurooncol; 2019 Sep; 144(2):283-291. PubMed ID: 31236820
[TBL] [Abstract][Full Text] [Related]
17. Treatment results of adults and children with medulloblastoma NCI, Cairo University experience.
Khalil EM
J Egypt Natl Canc Inst; 2008 Jun; 20(2):175-86. PubMed ID: 20029474
[TBL] [Abstract][Full Text] [Related]
18. [Medulloblastoma: improved survival in recent decades. Unicentric experience].
Igual Estellés L; Berlanga Charriel P; Cañete Nieto A
An Pediatr (Barc); 2017 Jan; 86(1):4-10. PubMed ID: 27068068
[TBL] [Abstract][Full Text] [Related]
19. Medulloblastoma in adults : A retrospective single institution analysis.
Hadi I; Roengvoraphoj O; Niyazi M; Roeder F; Schüller U; Belka C; Nachbichler SB
Strahlenther Onkol; 2018 Mar; 194(3):225-234. PubMed ID: 29147840
[TBL] [Abstract][Full Text] [Related]
20. Local control in non-metastatic medulloblastoma.
Christopherson KM; Bradley JA; Rotondo RL; Pincus DW; Fort JA; Morris CG; Mendenhall NP; Marcus RB; Indelicato DJ
Acta Oncol; 2014 Sep; 53(9):1151-7. PubMed ID: 24991891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]